Tag Archive for: protac
Harnessing PROTAC Technology: A Novel Approach to Targeting ERG in Prostate Cancer
/0 Comments/in Preclinical Research, PROTACs/by MaxProtac NP18: A New Hope for Prostate Cancer Treatment
/0 Comments/in Preclinical Research, PROTACs/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare alphafold antibody-drug conjugate apalutamide artificial intelligence ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy cancer treatment castration-resistant prostate cancer clinical trial clinical trials crispr darolutamide drug repurposing drug resistance enzalutamide hormone therapy HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic cancer metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA nanotechnology oncolytic virus personalized medicine prostate cancer PSMA radioligand therapy radiopharmaceuticals real-world data T-cell therapy theranostics
Latest Posts
- TALAPRO-2 Trial: Final OS Analisys Confirms Talazoparib + Enzalutamide Effectiveness in mCRPC May 22, 2025
- Scientists Uncover Key Protein Driving Cancer Spread to Bone, ASH1L May 22, 2025
- ACBP: Scientists Identify Key Protein Driving Bone Metastasis, Pointing to New Therapeutic Strategies May 22, 2025
- PT-112: FDA Clears Phase 3 Trial of Novel Therapy for Advanced Prostate Cancer May 21, 2025